Filtros de búsqueda

Lista de obras de Nancy K Gillis

An in vitro evaluation of guanfacine as a substrate for P-glycoprotein.

artículo científico

Atenolol induced HDL-C change in the pharmacogenomic evaluation of antihypertensive responses (PEAR) study

artículo científico publicado en 2013

Cancer therapy shapes the fitness landscape of clonal hematopoiesis

artículo científico publicado en 2020

Chipping in on clonal hematopoiesis

artículo científico publicado en 2017

Clinical implementation of germ line cancer pharmacogenetic variants during the next-generation sequencing era.

artículo científico publicado en 2013

Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case-control study

artículo científico publicado en 2016

Evidence required to demonstrate clinical utility of pharmacogenetic testing: the debate continues

scientific article published on 01 December 2014

Higher genetic diversity in introduced than in native populations of the mussel Mytella charruana: evidence of population admixture at introduction sites

article

Identification of Clonal Hematopoiesis Mutations in Solid Tumor Patients Undergoing Unpaired Next-Generation Sequencing Assays

artículo científico publicado en 2018

Incidence and Triggers of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in a Large Cancer Patient Cohort.

artículo científico publicado en 2017

Key Lessons Learned from Moffitt's Molecular Tumor Board: The Clinical Genomics Action Committee Experience

artículo científico publicado en 2017

Managing Clonal Hematopoiesis in Patients With Solid Tumors

artículo científico publicado en 2018

Quantitation of Targetable Somatic Mutations Among Patients Evaluated by a Personalized Medicine Clinical Service: Considerations for Off-Label Drug Use.

artículo científico publicado en 2017

The pharmacogenomics of drug resistance to protein kinase inhibitors.

artículo científico publicado en 2016

Tumor exome sequencing and copy number alterations reveal potential predictors of intrinsic resistance to multi-targeted tyrosine kinase inhibitors.

artículo científico publicado en 2017

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda